April's Reader Favorites
By Arvind Sommi
In case you missed them, below you’ll find our top stories from April 2023. This month’s best stories cover a wide variety of topics including medicare updates, upcoming therapies, new research findings, and more!
Are you getting enough vitamin D? Recent studies suggest that low vitamin D may be linked to an increased risk of developing type 2 diabetes and other health complications.
Diabetes jewelry is more than just a fashion statement – it’s a lifesaving accessory.
On April 16, Medicare began covering people with type 2 diabetes for continuous glucose monitors (CGMs).
Mark Cuban’s Cost Plus Drug Company recently added SGLT-2 inhibitor Invokana to its list of available medications. The company, which uses an innovative business model to provide drugs at heavily discounted prices, could potentially offer financial relief to millions of Americans.
Researchers released clinical trial data on a new treatment for type 2 diabetes that may help the body’s insulin-producing cells regenerate. 78% of the clinical trial’s participants who received the treatment reduced their A1C by at least 0.5 percentage points in four weeks.